IS BILE SALT-DEPENDENT LIPASE CONCENTRATION IN SERUM OF ANY HELP IN PANCREATIC-CANCER DIAGNOSIS

Citation
D. Lombardo et al., IS BILE SALT-DEPENDENT LIPASE CONCENTRATION IN SERUM OF ANY HELP IN PANCREATIC-CANCER DIAGNOSIS, Pancreas, 8(5), 1993, pp. 581-588
Citations number
33
Categorie Soggetti
Endocrynology & Metabolism",Physiology
Journal title
ISSN journal
08853177
Volume
8
Issue
5
Year of publication
1993
Pages
581 - 588
Database
ISI
SICI code
0885-3177(1993)8:5<581:IBSLCI>2.0.ZU;2-#
Abstract
The diagnostic value of bile salt-dependent lipase for pancreatic dise ases was tested in sera of 187 patients. Of these patients, 76 suffere d from pancreatic carcinoma, 43 from nonmalignant liver diseases (cirr hosis and chronic hepatitis), 18 from acute pancreatitis, and 20 from chronic pancreatitis. The remaining subjects were controls without pan creatic pathology. Bile salt-dependent lipase was determined by a sand wich enzyme-linked immunosorbent assay using polyclonal antibodies. Am ylase and CA 19-9 antigen were also determined. In sera from control p atients, the mean level of bile salt-dependent lipase was 1.5 mug/L. T his level is quite similar to that of patients with benign liver disea ses (1.1 mug/L) and with chronic pancreatitis (1.4 mug/L), but it was raised to 3.5 mug/L in patients with acute pancreatitis and decreased to 0.5 mug/L in subjects with pancreatic adenocarcinoma. Thirty percen t of control subjects and 73% of cancer patients had a bile salt-depen dent lipase serum level below the cutoff value of 0.5 mug/L. In acute pancreatitis, 11 of 16 subjects had levels above 1.5 mug/L. Amylase le vel largely increased in acute pancreatitis but was normal in all othe r groups. Concerning CA 19-9 antigen, 65% of control patients and >80% of patients with non-malignant pancreatic or liver diseases had norma l levels. In sera from cancer patients, 80% presented with high levels . Accordingly, 36 of 38 patients with pancreatic cancer had either low serum levels of bile salt-dependent lipase (<0.5 mug/L) or high value s of CA 19-9 antigen (>37 U/ml; sensitivity 95%). In control patients 2 of 30 had low levels of enzyme or elevated levels of CA 19-9 (specif icity 94%). Therefore, assay of the serum level of bile salt-dependent lipase, alone or more usefully in conjunction with CA 19-9 antigen, h elps to diagnose pancreatic carcinoma and to discriminate malignant di seases from either chronic or acute pancreatitis.